Trinity Biotech ROA 2006-2018 | TRIB

Current and historical return on assets (ROA) values for Trinity Biotech (TRIB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Trinity Biotech ROA for the three months ending September 30, 2018 was 1.30%.
Trinity Biotech ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.04B $0.18B -21.44%
2018-06-30 $-0.04B $0.19B -20.31%
2018-03-31 $-0.04B $0.20B -19.13%
2017-12-31 $-0.04B $0.19B -17.67%
2017-09-30 $-0.10B $0.25B -40.20%
2017-06-30 $-0.10B $0.25B -36.36%
2017-03-31 $-0.10B $0.25B -32.65%
2016-12-31 $-0.10B $0.25B -30.42%
2016-09-30 $0.00B $0.36B 0.83%
2016-06-30 $0.02B $0.36B 4.45%
2016-03-31 $0.02B $0.36B 4.73%
2015-12-31 $0.02B $0.36B 6.64%
2015-09-30 $0.02B $0.36B 7.63%
2015-06-30 $0.02B $0.36B 5.52%
2015-03-31 $0.02B $0.25B 6.63%
2014-12-31 $0.02B $0.24B 6.76%
2014-09-30 $0.02B $0.24B 7.31%
2014-06-30 $0.01B $0.24B 4.37%
2014-03-31 $0.01B $0.23B 4.54%
2013-12-31 $0.01B $0.23B 4.68%
2013-09-30 $0.01B $0.22B 4.36%
2013-06-30 $0.02B $0.20B 8.07%
2013-03-31 $0.02B $0.20B 8.27%
2012-12-31 $0.02B $0.20B 8.50%
2012-09-30 $0.02B $0.19B 8.80%
2012-06-30 $0.02B $0.18B 9.05%
2012-03-31 $0.02B $0.18B 9.26%
2011-12-31 $0.02B $0.17B 9.48%
2011-09-30 $0.02B $0.17B 9.62%
2011-06-30 $0.02B $0.17B 9.19%
2011-03-31 $0.06B $0.17B 38.87%
2010-12-31 $0.06B $0.16B 40.40%
2010-09-30 $0.06B $0.16B 41.74%
2010-06-30 $0.06B $0.15B 43.88%
2010-03-31 $0.01B $0.13B 9.14%
2009-12-31 $0.01B $0.13B 9.27%
2009-09-30 $-0.07B $0.13B -56.59%
2009-06-30 $-0.08B $0.13B -49.83%
2009-03-31 $-0.08B $0.13B -44.19%
2008-12-31 $-0.08B $0.13B -40.21%
2008-09-30 $-0.04B $0.22B -17.17%
2008-06-30 $-0.04B $0.22B -17.04%
2008-03-31 $-0.04B $0.21B -16.03%
2007-12-31 $-0.04B $0.22B -19.72%
2007-09-30 $0.01B $0.25B 4.31%
2007-06-30 $0.01B $0.25B 5.92%
2007-03-31 $0.01B $0.00B 4.85%
2006-12-31 $0.00B $0.25B 3.23%
2006-09-30 $0.00B $0.25B 2.78%
2006-06-30 $0.00B $0.00B 2.20%
2006-03-31 $0.01B $0.00B 3.82%
2005-12-31 $0.01B $0.19B 2.94%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.063B $0.099B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.916B 25.68
Medtronic (MDT) Ireland $122.526B 18.32
Stryker (SYK) United States $69.144B 25.38
Boston Scientific (BSX) United States $55.241B 26.97
Baxter (BAX) United States $38.548B 23.75
Zimmer Biomet Holdings (ZBH) United States $24.985B 16.03
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
ResMed (RMD) United States $14.250B 27.02
Canopy Growth (CGC) Canada $10.707B 0.00
Bio-Rad Laboratories (BIO) United States $7.832B 50.08
Aurora Cannabis (ACB) Canada $7.090B 50.71
Hill-Rom Holdings (HRC) United States $6.904B 21.35
Perrigo (PRGO) Ireland $6.603B 10.02
ICU Medical (ICUI) United States $5.119B 28.52
Insulet (PODD) United States $5.012B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.563B 0.00
Haemonetics (HAE) United States $4.395B 38.99
Agios Pharmaceuticals (AGIO) United States $3.341B 0.00
Hutchison China MediTech (HCM) China $3.330B 0.00
Neogen (NEOG) United States $3.259B 50.06
NuVasive (NUVA) United States $3.008B 27.99
National Vision Holdings (EYE) United States $2.570B 49.72
Quidel (QDEL) United States $2.529B 22.88
Aphria (APHA) $2.274B 101.00
NxStage Medical (NXTM) United States $1.945B 0.00
AtriCure (ATRC) United States $1.269B 0.00
VAREX IMAGING (VREX) United States $1.196B 23.42
Phibro Animal Health (PAHC) United States $1.192B 17.13
Cardiovascular Systems (CSII) United States $1.151B 826.00
HEXO (HEXO) $1.127B 0.00
MacroGenics (MGNX) United States $0.893B 0.00
Cerus (CERS) United States $0.848B 0.00
PetIQ (PETQ) United States $0.821B 21.28
Evolus (EOLS) United States $0.744B 0.00
Surmodics (SRDX) United States $0.724B 105.35
NanoString Technologies (NSTG) United States $0.721B 0.00
Lantheus Holdings (LNTH) United States $0.711B 22.00
OraSure Technologies (OSUR) United States $0.707B 31.19
Omeros (OMER) United States $0.703B 0.00
Meridian Bioscience (VIVO) United States $0.698B 20.80
Eagle Pharmaceuticals (EGRX) United States $0.604B 19.39
Quanterix (QTRX) United States $0.491B 0.00
LeMaitre Vascular (LMAT) United States $0.486B 23.89
Owens & Minor (OMI) United States $0.470B 5.32
TG Therapeutics (TGTX) United States $0.390B 0.00
Insys Therapeutics (INSY) United States $0.355B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.98
BioLife Solutions (BLFS) United States $0.285B 385.00
Bovie Medical (APYX) United States $0.283B 0.00
Vapotherm (VAPO) United States $0.279B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.272B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.228B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.152B 0.00
Fonar (FONR) United States $0.147B 7.87
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.11
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.079B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.033B 0.00
Senestech (SNES) United States $0.020B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14